A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)

APTITUDE Trial Management Group

Research output: Contribution to journalArticle (Academic Journal)peer-review

10 Citations (Scopus)
168 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)'. Together they form a unique fingerprint.

Medicine & Life Sciences